The company has now had two extremely successful P3 trials completed for two different indications: Rett and AD. This is extraordinary and despite the stock price not yet reacting, the CEO and everyone in the company is entitled to take a bow and receive a bonus.
Totally agree w/this...put our big boy pants on a keep moving up the hill.